Momentum and debate about the application of cost-effectiveness analysis to determine the value and prices of prescription drugs in the...

Background

The Medicines & Healthcare products Regulatory Agency (MHRA) is holding an open consultation to gather views on possible...

The Medicines and Medical Devices Act 2021 (the “MMD Act”) was granted royal assent on 11th February 2021. The MMD Act confers broad...

On 23 February 2021, an update was published to the British Medicines and Healthcare products Regulatory Agency's (MHRA) Guidance on the...

The global outlook for M&A in the digital health and particularly the telehealth sector has never been brighter than today.

At a time when the importance of the life sciences industry to our daily lives has never been clearer, the UK Government has been...

On 11 February 2021, the Department of Health and Social Care published a white paper - Integration and innovation: working together to...

For the first time, in Eli Lilly v Actavis the UK Supreme Court has introduced a doctrine of equivalence in an effort to move closer to...